Related Experiment Video
Updated: Jan 18, 2026

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
Published on: May 2, 2025
[The role of metformin in the cardiokidney-metabolic patient]
E Arranz Martínez1, C Hernández-Teixidó2, A Ruíz García3
1Medicina de Familia, Centro de Salud San Blas, Parla, Madrid, España; Grupo de Trabajo de Diabetes, Endocrinología y Metabolismo, Semergen, España.
Abstract:
Metformin is a first-line drug in the treatment of type2 diabetes mellitus (T2DM) due to its efficacy, safety, and cost-effectiveness. Its main mechanism of action is the reduction of hepatic gluconeogenesis, improving insulin sensitivity and modulating glucose metabolism. The benefits of metformin are not limited to glycemic control, as it also has cardiovascular effects, reducing the risk of acute myocardial infarction and cardiovascular mortality in people with T2DM. Additionally, it has positive effects on lipid metabolism, metabolic dysfunction-associated liver disease, and pulmonary pathology, as well as potential effects in preventing cancer and neurodegenerative diseases. Its impact on aging and the gut microbiota remains an area of ongoing research.
Related Concept Videos
Oral Hypoglycemic Agents: Biguanides and Glitazones
Chronic Kidney Disease III: Interprofessional Care
Heart Failure Drugs: Diuretics
Acute Kidney Injury V: Interprofessional Care
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Kidney Transplant I: Introduction
